Concepedia

Publication | Closed Access

Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial

DOI

39

Citations

11

References

2017

Year

D. Robert Siemens, Laurence Klotz, Axel Heidenreich, Simon Chowdhury, Arnauld Villers, Benoît Baron, Steve van Os, Nahla Hasabou, Fong Wang, Ping Lin,
The Journal of Urology

Abstract

Enzalutamide improved clinical outcomes vs bicalutamide irrespective of age. Increased falls and cardiac events suggest caution when prescribing to older patients (age 75 years or greater) with significant comorbidity.

References

YearCitations

Page 1